Super Administrators can edit or delete any rule set. If the originator of the rule set wants other administrators to edit the rule set, he will need to share access in order to work collaboratively by adding co-authors. Brands and agencies Craft and amplify your message with our custom content creation and distribution services. This in turn helps you manage the lifecycle of the incident more efficiently.
Access direct in-context diagnostic/action links to relevant Enterprise Manager functionality allowing you to quickly diagnose or resolve the incident. Proc Natl Acad Sci U S A 95: 1195–1200. 56. Vainchenker W, Delhommeau F, Constantinescu SN, Bernard OA (2011) New mutations and pathogenesis of myeloproliferative neoplasms. Marrow cellularities were determined with two tibias from each mouse and significant differences were not found between any of the control and transgenic animals. Blood 100: 1302–1309. 6. Dykstra B, Kent D, Bowie M, McCaffrey L, Hamilton M, et al. (2007) Long-term propagation of distinct hematopoietic differentiation programs in vivo. These incidents typically need to be tracked, assigned to appropriate personnel, and resolved as quickly as possible.
With previous versions of Enterprise Manager, you used notification rules to choose the individual targets and conditions for which you want to perform actions or receive notifications (send email, page, open a helpdesk ticket) from Enterprise Manager. Blood 107: 4274–4281. 18. Lacout C, Pisani DF, Tulliez M, Gachelin FM, Vainchenker W, et al. (2006) JAK2V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis. Blood 120: 166–172. 30. Chen E, Beer PA, Godfrey AL, Ortmann CA, Li J, et al. (2010) Distinct clinical phenotypes associated with JAK2V617F reflect differential STAT1 signaling. Earlier studies associated those properties with overlapping populations of HSC that are poor at replenishing the adaptive immune system –. Possibly related to that, JAK2 transgenic HSC had elevated expression of two transcription factors required for erythropoiesis. This could suggest that the immune systems of patients with JAK2 mutations are not being replenished to a normal degree. The conditional action that updated the incident will not be matched again in the same rule application cycle. 126.96.36.199.2 Rule Criteria The following tables list selectable criteria for each type.